SCR-LIP-000614 · Claim · machine-readable JSON →

Thyroid disease or hypothyroidism is reported more often in lipedema than in general-population or clinical comparison groups in unadjusted cross-sectional comparisons.

General proposition consolidated from 4 earlier single-paper claims; each study's own result is shown as its finding.

Claim at a glance
Type
clinical association
Knowledge state
Emerging
Evidence certainty
low (GRADE)
Evidence
5 source(s)
Dates
2026-11-20 → 2026-11-20

Structured evidence, machine-compiled — not a verdict.

Evidence over time

20192026New Insights on Lipedema: The Enigmatic Disease of the Peripheral Fat — Bauer et al. (2019) · consistentDisease progression and comorbidities in lipedema patients: A 10‐year retrospective analysis — Ghods et al. (2020) · contextualVenous thromboembolic outcomes in patients with lymphedema and lipedema: An analysis from the National Inpatient Sample — Khalid et al. (2024) · consistentLipedema and Hypermobility Spectrum Disorders Sharing Pathophysiology: A Cross-Sectional Observational Study — Fiengo & Sbarbati (2025) · consistentPrevalence of comorbidities associated with lipedema. A comparative study with the general population — Vaquero-Ramiro et al. (2026) · consistent

Evidence (5)

Context (PECO)

PopulationSpanish women with lipedema (n=1001)
Conditionlipedema
Exposurelipedema diagnosis
Comparatorgeneral Spanish female population
Outcomeprevalence of thyroid disease (OR=2.21)
Scopeauto-ingested from Layer 1 surveillance

Answers these questions

Gaps & caveats

Change log